What Analysts Think of Argos Therapeutics (ARGS)?

Therefore 75% are positive.

For the current quarter Argos Therapeutics (NASDAQ:ARGS) has average revenue estimates of $50 Million, a total number of 1 analysts provided estimations over revenues. Relative volume is the comparison of current volume to average volume for the same time of day, and it's displayed as a ratio. The company has market cap of $11.85 million.

Shares of Argos Therapeutics (NASDAQ:ARGS) has a market capitalization of $15.47 Million and its number of outstanding shares are 94.9 Million. The rating was maintained by Needham with "Buy" on Tuesday, November 17. The New York-based Virtu Llc has invested 0% in Argos Therapeutics, Inc. The firm acquired 665,831 shares of the biopharmaceutical company's stock, valued at approximately $120,000.

Right now, ARGS's beta is 1.41. (AFGE) has $9.45B valuation. This will give analytical advantage to a shorter-term trader since it pursues the price more intimately, and consequently produces less "lag" as comparison to the longer-term moving average. Chipotle Mexican Grill, Inc. (NYSE:AFGE) has declined 0.59% since January 19, 2017 and is downtrending.

Argos Therapeutics, Inc (Argos) is an immuno-oncology company. During previous trade 2.65 Million shares of Argos Therapeutics (NASDAQ:ARGS) exchanged hands whereas on average nearly 4.74 Million shares has been traded. The Company's Arcelis technology platform utilizes biological components from a patient's own cancer cells or virus to generate individualized immunotherapies. It now has negative earnings. At the moment several experts are conducting its evaluation in the pivotal ADAPT Phase 3 clinical trial which is specifically targeted towards the treatment of metastatic renal cell carcinoma (mRCC). It tells an investor how quickly a company is increasing its revenues. Its up 0.09, from 0.54 in 2017Q2. Argos Therapeutics, Inc. (NASDAQ:ARGS) has a 20-Day average volume of 4.68 Million. Argos Therapeutics (NASDAQ:ARGS)'s price to earnings ratio stood at 0. Northern Trust holds 43,244 shares. Also, Argos Therapeutics, Inc. Wasatch Advisors Inc. purchased a new position in Argos Therapeutics Inc (NASDAQ:ARGS) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. (NASDAQ:ARGS) advice adding it to buy candidate list. Bnp Paribas Arbitrage accumulated 4 shares or 0% of the stock.

Are Argos Therapeutics, Inc. That suggests something of the likelihood of a short squeeze in shares of ARGS. Moreover, Vanguard Grp has 0% invested in Argos Therapeutics, Inc. (NASDAQ:ARGS)'s near-term growth potential.

More news for Argos Therapeutics, Inc.

Taking a broader look brokerage firms' analysts on the street with an expectant view have Argos Therapeutics (NASDAQ:ARGS) high price target of $0.75 and with a conservative view have low price target of $0.75. Barclays Pcl holds 100 shares.

The stock decreased 12.84% or $0.0206 during the last trading session, reaching $0.1398. Whereas, in last 21 trading days (one month) was -2.71% and moved down in last 63 trading days (quarter) of -17.71%. 1 is equivalent to a buy rating, 3 a hold rating, and 5 a sell rating. It has underperformed by 109.27% the S&P500. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Chipotle Mexican Grill Inc. had 211 analyst reports since July 22, 2015 according to SRatingsIntel. A high degree of volume indicates a lot of interest in a stock. The rating was maintained by Jefferies with "Sell" on Wednesday, July 19.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter. The rating was downgraded by Wells Fargo to "Market Perform" on Wednesday, July 19. The firm has "Neutral" rating by Wedbush given on Thursday, January 5. The firm has "Underperform" rating by Cowen & Co given on Friday, September 8. Netflix Inc (NASDAQ:NFLX) was reduced too.

Related:

Comments

Latest news

Arsenal running out of time to get Jonny Evans
Both managers have had to deal with injury issues at the back and City missed out on their top target, Virgil van Dijk, earlier this month.

Details of Mkhitaryan's contract with Arsenal revealed
The Red Devils are set to announce the deal today, which is being hailed as a major coup for executive vice chairman Ed Woodward. Mkhitaryan, 28, will have a medical on Sunday and Monday after the paperwork for his transfer was completed on Saturday.

Nokia 7 or Nokia 6 (2018) coming soon to the US
As far as the reports are concerned, HMD Global has already designed the smartphone and is expected to start testing it very soon. The source says if Foxconn is able to find a way to mass produce it, we may see this spectacular phone launch later this year.

Makers of Padmaavat likely to postpone Rajasthan release
Despite the court ruling, protesters have not backed down, especially in Rajasthan and Gujarat. The court agreed for an early hearing and posted the matter for arguments on Tuesday.

Corning Inc. (NYSE:GLW)
Mason Street Advisors Limited Liability Company holds 0.12% of its portfolio in Domino's Pizza, Inc. (NYSE:HF) for 84,741 shares. It increased, as 40 investors sold AMAT shares while 325 reduced holdings. 55 funds opened positions while 110 raised stakes.

Other news